PTPRC and neoplasm: We found several molecules that are significant in tumor initiation and treatment by immune checkpoint analysis, such as lymphocyte-activation gene 3 (LAG3), PTPRC, HAVCR2, B2M, LDHA, and LDHB, which may be used as a reference for tumor immunotherapy (Fig. 6A).